// App-Quantinova.ai

OP051 : Two-year clinical outcome of patients treated with the Nobori biolimus-eluting stent and XIENCE everolimus-eluting stent for unprotected left main disease

Researchers

Presenter

  • Hiromasa T

Principal Investigators

  • Kuramitsu S

  • Morinaga T

  • Kobayashi Y

  • Jinnouchi H

  • Domei T

  • Hyodo M

  • Soga Y

  • Shirai S

  • Ando K

  • Nobuyoshi M

Medical Centers

  • Kokura memorial hospital, Kitakyusyu, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Left main disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

  • Crofelemer

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved